import – Lab DB

Pharmaceutical R&D

US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs

Teuku Ryan Apr 8, 2026 0

The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…

US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs

YOU MAY HAVE MISSED

Breakthrough High-Resolution Imaging Technique Unlocks Hidden Complexities of Mouse Bone Marrow for Advanced Disease Research

A novel immune organ inside the skull directs brain defense and may offer a new way to fight brain cancer and neurodegenerative disease

The oral exposure challenge in PROTACs: What drug developers need to solve early

Attention Unleashed: Rethinking ADHD as a Conduit for Creative Innovation in the Modern Neurological Landscape